#GcMAF – the beginning of the end for #autism

(PRWEB UK) 8 September 2012

Dr Bradstreet has treated 600 children with GcMAF in the USA and will publicise some of his results at the Treating Autism Conference on September 9th and in a paper being published afterwards.

Dr Bradstreet tested hundreds of children for Nagalase and found over 80% had high levels. High Nagalase levels indicates the presence of viruses and a severely weakened immune system. 46 research papers by 107 eminent scientists prove GcMAF restores the immune system, and reduces nagalase down to healthy levels.

Dr Nicola Antonucci in Italy treated 94 children with autism, 83 had significant improvements, and he believes GcMAF to be the most effective treatment of autism. It is essential to ensure the GCMAF has been tested with live cell (eg macrophage cell) assays, or it may not be active.

GcMAF is a key component of our immune system: all healthy people have it, people with chronic diseases do not. Immuno Biotech Ltd ( extracts and purifies GcMAF in their Oxford laboratories and supplied all four clinics in the above studies.

Commonly reported improvements are cognitive abilities, attention and focus, learning and understanding, receptiveness and awareness to the environment; language abilities both in speech and understanding; social skills and improvements in behaviour and appropriateness.

Side effects are minimal. They can include a low grade fever for a few hours as the immune system starts to tackle viruses, and if the dose is too high, an initial aggravation of some of the symptoms, such as anger and aggression which wears off after two to three weeks. Many show no side effects.

Daniel's case is not unusual. Now aged 5, he was diagnosed with severe autism at aged 2 ½. His family had tried a casein free, gluten free and, more recently, ketogenic diet for his digestive problems. All factory food was avoided, as were sugars, wheat, peanuts and yeast.

However, despite many medications, Daniel did not see significant improvement until he was put onto GcMAF. Almost from the first injection, a new calm settled over the household.

Between the 5th and 6th injections, Daniel became a lot more aware of his surroundings and more spontaneous with his language. By week 7, his parents were reporting that he was the most engaged with life they had ever seen him. Unlike previous treatments, there was no regression.

At about 8 weeks he started to recognise pictures and went from struggling with a six piece jigsaw to completing a 48 piece puzzle. Daniel had seen improvements in composure, language, awareness and relationships:

By the 16th shot, he was more spontaneous and articulate than ever before, and his clostridia infection had cleared up. It had caused distressing Tourette outbursts which antibiotics had failed to eradicate, but these ceased. There has been no recurrence for the past six months. He is catching up on his learning; his speech and understanding has blossomed, and so he doesn't regress, he will stay on GcMAF for a few more weeks until his Nagalase result is below 0.62, to ensure his body's own GcMAF has taken over from Immuno Biotech's.